Literature DB >> 8289356

Herpesvirus-induced cell fusion that is dependent on cell surface heparan sulfate or soluble heparin.

M T Shieh1, P G Spear.   

Abstract

The entry of enveloped viruses into animal cells and the cell-to-cell spread of infection via cell fusion require the membrane-fusing activity of viral glycoproteins. This activity can be dependent on variable cell factors or triggered by environmental factors. Here we show that cell fusion induced by herpes simplex virus glycoproteins is dependent on the presence of cell surface glycosaminoglycans, principally heparan sulfate, or on the addition of heparin to the medium. The role of the glycosaminoglycan is probably to alter the conformation of a viral heparin-binding glycoprotein required for the fusion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8289356      PMCID: PMC236566          DOI: 10.1128/JVI.68.2.1224-1228.1994

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  The isolation and properties of a variant of Herpes simplex producing multinucleated giant cells in monolayer cultures in the presence of antibody.

Authors:  M D HOGGAN; B ROIZMAN
Journal:  Am J Hyg       Date:  1959-09

2.  A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis.

Authors:  K Lidholt; J L Weinke; C S Kiser; F N Lugemwa; K J Bame; S Cheifetz; J Massagué; U Lindahl; J D Esko
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

3.  Membrane proteins specified by herpes simplex viruses. III. Role of glycoprotein VP7(B2) in virion infectivity.

Authors:  M Sarmiento; M Haffey; P G Spear
Journal:  J Virol       Date:  1979-03       Impact factor: 5.103

4.  Membrane proteins specified by herpes simplex viruses. IV. Conformation of the virion glycoprotein designated VP7(B2).

Authors:  M Sarmiento; P G Spear
Journal:  J Virol       Date:  1979-03       Impact factor: 5.103

5.  Cell fusion induced by herpes simplex virus is promoted and suppressed by different viral glycoproteins.

Authors:  R Manservigi; P G Spear; A Buchan
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

6.  A cell line expressing vesicular stomatitis virus glycoprotein fuses at low pH.

Authors:  R Z Florkiewicz; J K Rose
Journal:  Science       Date:  1984-08-17       Impact factor: 47.728

7.  Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment.

Authors:  T J Wickham; P Mathias; D A Cheresh; G R Nemerow
Journal:  Cell       Date:  1993-04-23       Impact factor: 41.582

8.  Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion.

Authors:  J J Skehel; P M Bayley; E B Brown; S R Martin; M D Waterfield; J M White; I A Wilson; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

9.  DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel; G Urlaub; L Chasin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

10.  A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H.

Authors:  C Roop; L Hutchinson; D C Johnson
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

View more
  33 in total

1.  Characterization of a BHK(TK-) cell clone resistant to postattachment entry by herpes simplex virus types 1 and 2.

Authors:  R J Roller; B C Herold
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Partial resistance to gD-mediated interference conferred by mutations affecting herpes simplex virus type 1 gC and gK.

Authors:  P E Pertel; P G Spear
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Site-directed and linker insertion mutagenesis of herpes simplex virus type 1 glycoprotein H.

Authors:  M Galdiero; A Whiteley; B Bruun; S Bell; T Minson; H Browne
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

4.  An endoplasmic reticulum-retained herpes simplex virus glycoprotein H is absent from secreted virions: evidence for reenvelopment during egress.

Authors:  H Browne; S Bell; T Minson; D W Wilson
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

5.  Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM.

Authors:  A V Nicola; M Ponce de Leon; R Xu; W Hou; J C Whitbeck; C Krummenacher; R I Montgomery; P G Spear; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 6.  Microbial adherence to and invasion through proteoglycans.

Authors:  K S Rostand; J D Esko
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

Review 7.  Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management.

Authors:  Michael J Bradshaw; Arun Venkatesan
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

8.  Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread.

Authors:  S Laquerre; R Argnani; D B Anderson; S Zucchini; R Manservigi; J C Glorioso
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  HveA (herpesvirus entry mediator A), a coreceptor for herpes simplex virus entry, also participates in virus-induced cell fusion.

Authors:  T Terry-Allison; R I Montgomery; J C Whitbeck; R Xu; G H Cohen; R J Eisenberg; P G Spear
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry.

Authors:  B C Herold; S I Gerber; B J Belval; A M Siston; N Shulman
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.